Description

Tirzepatide (Lyophilized)

Chemical Classification: Dual GIP/GLP-1 Receptor Agonist Molecular Formula:  Molecular Weight:  g/mol

Research Overview

Tirzepatide is a 39-amino-acid synthetic peptide designed as a dual-pathway agonist. It is a primary subject in metabolic research due to its unique ability to bind simultaneously to both the glucose-dependent insulinotropic polypeptide (GIP) and the glucagon-like peptide-1 (GLP-1) receptors.

Common Research Applications

This peptide is frequently utilized in laboratory settings to investigate the following experimental objectives:

• Incretin System Synergy: Studies focusing on the potentiation of insulin secretion and the comparative analysis of dual-pathway agonism versus mono-agonist (GLP-1 only) models.
• Adipocyte Metabolism: Research regarding the regulation of lipid storage, lipolysis rates, and the physiological responses of white adipose tissue to dual-receptor stimulation.
• Glucose Homeostasis: Investigations into the suppression of glucagon secretion and the modulation of gastric emptying rates in non-human experimental subjects.
• Neuro-Metabolic Signaling: Exploration of the peptide’s affinity for receptors within the central nervous system that govern appetite signaling and nutrient-stimulated hormone responses.
• Cardiovascular & Inflammatory Pathways: Emerging research into the secondary effects of dual-incretin mimetics on systemic inflammatory markers and vascular endothelial function.

Laboratory Handling & Storage

• Appearance: Lyophilized white powder.
• Reconstitution: For laboratory use, reconstitution in bacteriostatic water or sterile saline is standard.

Stability: Stable at room temperature for transit. For long-term preservation, store at -20°C. Once reconstituted, maintain at 2°C – 8°C